Then, in order to identify the inhibitory mechanisms of the CAt extract in HCC xenografts, the protein expression of PCNA, VEGF, VEGFR1, and VEGFR2 were examined by immunohistochemical (IHC) staining. The gene discussed is FLT1; the disease is hepatocellular carcinoma.